{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:51:32Z","timestamp":1791453092534,"version":"4.3.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06853-9","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:10:30Z","timestamp":1791450630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retroperitoneal lymph node dissection for isolated node recurrence of renal cell carcinoma after nephrectomy: a systematic review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-7206","authenticated-orcid":false,"given":"Alberto","family":"Costa Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Gulamhusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"6853_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.020","author":"A Bex","year":"2025","unstructured":"Bex A et al (2025) European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020","journal-title":"\u00a0Eur Urol"},{"issue":"2","key":"6853_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jso.23473","volume":"109","author":"P Paparel","year":"2014","unstructured":"Paparel P et al (2014) Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. A multi-institutional study. J Surg Oncol 109(2):126\u2013131. https:\/\/doi.org\/10.1002\/jso.23473","journal-title":"J Surg Oncol"},{"key":"6853_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2019.05.007","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Lehrer EJ, Kothari G, Louie AV, Siva S (2019) Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2019.05.007","journal-title":"Eur Urol Oncol"},{"key":"6853_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2022.08.016","author":"JL Guevelou","year":"2023","unstructured":"Guevelou JL et al (2023) The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic Review. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2022.08.016","journal-title":"Eur Urol Focus"},{"key":"6853_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193334","author":"CJQ Villafuerte","year":"2024","unstructured":"Villafuerte CJQ, Swaminath A (2024) Stereotactic Body Radiotherapy for Renal Cell Carcinoma\u2014A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings. Cancers. https:\/\/doi.org\/10.3390\/cancers16193334","journal-title":"Cancers"},{"key":"6853_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"6853_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","author":"JA Sterne","year":"2016","unstructured":"Sterne JA et al (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online). https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ (Online)"},{"issue":"3","key":"6853_CR8","doi-asserted-by":"publisher","first-page":"111.e27","DOI":"10.1016\/j.urolonc.2021.11.028","volume":"40","author":"M Stan\u00edk","year":"2022","unstructured":"Stan\u00edk M et al (2022) Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy. Urol Oncol 40(3):111.e27-111.e34. https:\/\/doi.org\/10.1016\/j.urolonc.2021.11.028","journal-title":"Urol Oncol"},{"issue":"9","key":"6853_CR9","doi-asserted-by":"publisher","first-page":"739.e1","DOI":"10.1016\/j.urolonc.2020.06.006","volume":"38","author":"MP Barboza","year":"2020","unstructured":"Barboza MP et al (2020) Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma. Urol Oncol 38(9):739.e1-739.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.006","journal-title":"Urol Oncol"},{"key":"6853_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.urology.2020.07.060","volume":"145","author":"R Ghandour","year":"2020","unstructured":"Ghandour R et al (2020) Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence After Nephrectomy for Renal Cell Carcinoma. Urology 145:159\u2013165. https:\/\/doi.org\/10.1016\/j.urology.2020.07.060","journal-title":"Urology"},{"issue":"6","key":"6853_CR11","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1111\/bju.13212","volume":"117","author":"CM Russell","year":"2016","unstructured":"Russell CM et al (2016) Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma. BJU Int 117(6):E60\u2013E66. https:\/\/doi.org\/10.1111\/bju.13212","journal-title":"BJU Int"},{"issue":"2","key":"6853_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.juro.2014.02.010","volume":"192","author":"CM Russell","year":"2014","unstructured":"Russell CM et al (2014) Surgical outcomes in the management of isolated nodal recurrences: A multicenter, international retrospective cohort. J Urol 192(2):350\u2013356. https:\/\/doi.org\/10.1016\/j.juro.2014.02.010","journal-title":"J Urol"},{"key":"6853_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1089\/end.2010.0051","volume":"24","author":"J Yohannan","year":"2010","unstructured":"Yohannan J, Feng T, Berkowitz J, Connolly SS, Pierorazio P, Allaf ME (2010) Laparoscopic Resection of Local Recurrence After Previous Radical Nephrectomy for Clinically Localized Renal-Cell Carcinoma: Perioperative Outcomes and Initial Observations. J Endourol 24:1609\u20131612","journal-title":"J Endourol"},{"issue":"1","key":"6853_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.juro.2008.03.025","volume":"180","author":"SA Boorjian","year":"2008","unstructured":"Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML (2008) Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. J Urol 180(1):99\u2013103. https:\/\/doi.org\/10.1016\/j.juro.2008.03.025","journal-title":"J Urol"},{"key":"6853_CR15","doi-asserted-by":"publisher","unstructured":"Bhindi B et al (2018) The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. Blackwell Publishing Ltd May 01. https:\/\/doi.org\/10.1111\/bju.14127","DOI":"10.1111\/bju.14127"},{"issue":"1","key":"6853_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","volume":"55","author":"JHM Blom","year":"2009","unstructured":"Blom JHM et al (2009) \u201cRadical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881,.\u201d Eur Urol 55(1):28\u201334. https:\/\/doi.org\/10.1016\/j.eururo.2008.09.052","journal-title":"Eur Urol"},{"issue":"2","key":"6853_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/bju.12508","volume":"114","author":"U Capitanio","year":"2014","unstructured":"Capitanio U et al (2014) Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int 114(2):210\u2013215. https:\/\/doi.org\/10.1111\/bju.12508","journal-title":"BJU Int"},{"issue":"8","key":"6853_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/bco2.375","volume":"5","author":"G Bencina","year":"2024","unstructured":"Bencina G et al (2024) \u201cRecurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort,.\u201d BJUI Compass 5(8):791\u2013798. https:\/\/doi.org\/10.1002\/bco2.375","journal-title":"BJUI Compass"},{"key":"6853_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21869","author":"S Dudani","year":"2021","unstructured":"Dudani S et al (2021) \u201cEvaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival,.\u201d JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.21869","journal-title":"JAMA Netw Open"},{"issue":"23","key":"6853_CR20","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1002\/cam4.4790","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) \u201cLocoregional recurrence after nephrectomy for localized renal cell carcinoma: feasibility and outcomes of different treatment modalities,.\u201d Cancer Med 11(23):4430\u20134439. https:\/\/doi.org\/10.1002\/cam4.4790","journal-title":"Cancer Med"},{"key":"6853_CR21","doi-asserted-by":"publisher","unstructured":"Lasorsa F et al (2025) Histopathology and outcomes of non-metastatic renal cell carcinoma with inferior vena cava tumor thrombus: systematic review and meta-analysis, W.B. Saunders Ltd. https:\/\/doi.org\/10.1016\/j.ejso.2025.110491","DOI":"10.1016\/j.ejso.2025.110491"},{"key":"6853_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040767","author":"L Napolitano","year":"2023","unstructured":"Napolitano L et al (2023) Cytoreductive nephrectomy and metastatic renal cell carcinoma: state of the art and future perspectives. Medicina (Kaunas, Lithuania). https:\/\/doi.org\/10.3390\/medicina59040767","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"15","key":"6853_CR23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/nejmoa2312695","volume":"390","author":"TK Choueiri","year":"2024","unstructured":"Choueiri TK et al (2024) Overall survival with adjuvant pembrolizumab in renal-cell carcinoma. N Engl J Med 390(15):1359\u20131371. https:\/\/doi.org\/10.1056\/nejmoa2312695","journal-title":"N Engl J Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06853-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06853-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06853-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:10:31Z","timestamp":1791450631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06853-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6853"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06853-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Declaration of generative AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"734"}}